SCHEMBL19295121

SCHEMBL19295121

CN(C)c1nc(Cl)nc(N2CCCC2)n1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ CYP1A2 P05177 2/20 0.43
▸ TP53 P04637 1/20 0.42
▸ MAPK1 P28482 2/20 0.42
▸ LMNA P02545 2/20 0.40
▸ TSHR P16473 1/20 0.40
▸ ATM Q13315 2/20 0.39
▸ HTT P42858 2/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ RECQL P46063 1/20 0.39
▸ PDE4A P27815 2/20 0.39
▸ PDE4B Q07343 1/20 0.39
▸ PDE4C Q08493 1/20 0.39
▸ PDE4D Q08499 1/20 0.39
▸ HRH1 P35367 1/20 0.38
▸ USP2 O75604 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11552038 0.98 ALDH1A1 (0.45) SMN1; SMN2ALDH1A1CYP1A2TP53MAPK1
SCHEMBL8535478 0.84 SMN1; SMN2 (0.61) SMN1; SMN2ALDH1A1CYP1A2MAPK1LMNA
SCHEMBL9336873 0.80 HRH1 (0.50) SMN1; SMN2ALDH1A1CYP1A2TP53MAPK1
SCHEMBL9073359 0.80 HRH1 (0.56) SMN1; SMN2ALDH1A1CYP1A2TP53MAPK1
SCHEMBL15671736 0.79 HRH4 (0.44) SMN1; SMN2ALDH1A1CYP1A2TP53MAPK1
SCHEMBL2453047 0.78 ALDH1A1 (0.46) SMN1; SMN2ALDH1A1CYP1A2TP53MAPK1
SCHEMBL8422457 0.78 SMN1; SMN2 (0.58) SMN1; SMN2ALDH1A1CYP1A2TP53MAPK1
SCHEMBL778332 0.78 SMN1; SMN2 (0.52) SMN1; SMN2ALDH1A1CYP1A2TP53MAPK1
SCHEMBL2242665 0.78 SMN1; SMN2 (0.52) SMN1; SMN2ALDH1A1CYP1A2TP53MAPK1
SCHEMBL1090112 0.78 SMN1; SMN2 (0.58) SMN1; SMN2ALDH1A1CYP1A2TP53MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3174890-B1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2019-03-13 — — EP disclosed
US-9853228-B2 Metal complexes MERCK PATENT GMBH (DE) 2017-12-26 — — US disclosed
US-9853228-B2 Metal complexes MERCK PATENT GMBH (DE) 2017-12-26 — — US disclosed
US-20170250353-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2017-08-31 — — US disclosed
US-20170250353-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2017-08-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170250353-A1 METAL COMPLEXES SOD1, AP1M1, AP3M1 SMN1; SMN2 3736/4885ALDH1A1 3721/4885CYP1A2 3647/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback